Abstract:CRISPR-based diagnostics (CRISPR/Dx) have revolutionized the field of molecular diagnostics. It enables home self-test, field-deployable, and point-of-care testing (POCT). Despite the great potential of CRISPR/Dx in diagnoses of biologically complex diseases, preamplification of the template often is required for the sensitive detection of low-abundance nucleic acids. Various amplification-free CRISPR/Dx systems were recently developed to enhance signal detection at sufficient sensitivity. Broadly, these amplification-free CRISPR/Dx systems are classified into five groups depending on the signal enhancement strategies employed: CRISPR/Cas12a and/or CRISPR/Cas13a are integrated with: (1) other catalytic enzymes (Cas14a, Csm6, Argonaute, duplex-specific nuclease, nanozyme, or T7 exonuclease), (2) rational-designed oligonucleotides (multivalent aptamer, tetrahedral DNA framework, RNA G-quadruplexes, DNA roller machine, switchable-caged guide RNA, hybrid locked RNA/DNA probe, hybridized cascade probe, or "U" rich stem-loop RNA), (3) nanomaterials (nanophotonic structure, gold nanoparticle, micromotor, or microbeads), (4) electrochemical and piezoelectric plate biosensors (SERS nanoprobes, graphene field-effect transistor, redox probe, or primer exchange reaction), or (5) cutting-edge detection technology platforms (digital bioanalysis, droplet microfluidic, smartphone camera, or single nanoparticle counting). Herein, we critically discuss the advances, pitfalls and future perspectives for these amplification-free CRISPR/Dx systems in nucleic acids detection. The continued refinement of these CRISPR/Dx systems will pave the road for rapid, cost-effective, ultrasensitive, and ultraspecific on-site detection without resorting to target amplification, with the ultimate goal of establishing CRISPR/Dx as the paragon of diagnostics.

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

CRISPR Cas system: A strategic approach in detection of nucleic acids

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms

Harnessing CRISPR/Cas Systems for DNA and RNA Detection: Principles, Techniques, and Challenges

Amplification-free nucleic acids detection with next-generation CRISPR/dx systems

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

Amplification-free CRISPR/Cas detection technology: challenges, strategies, and perspectives.

CRISPR/Cas Systems towards Next-Generation Biosensing

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

CRISPR molecular detection techniques: Advances from single to multiple detection methods

CRISPR/Cas-Powered Amplification-Free Detection of Nucleic Acids: Current State of the Art, Challenges, and Futuristic Perspectives

The CRISPR-Cas System in Molecular Diagnostics

Next-generation CRISPR-based Diagnostic Tools for Human Diseases